Drugs Made In America Acquisition DMIIR Ratios (2025-2026)

NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT
Reported Financials

Drugs Made In America Acquisition Quarterly Ratios

Periods 3 quarters
Latest Jun 2026

Drugs Made In America Acquisition ratios data for the quarter ended Jun 2026. These financial ratios cover 3 quarters of results from Sep 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 250.57M502.98M509.53M
Return Ratios
Return on Assets [ROA]ROA 0.00%